Analysts expect Denali Therapeutics Inc. to report revenue of 13.07 M for Q3 26, against a range of 12.44 M to 13.70 M. The most recent reported quarter, Q2 26, came in at 3.60 M, a 62.8% beat against the 2.21 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.60 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 7.22 M | 10.69 M | 1.42 M | 7.43 M | 1.57 M | 3.12 M | 2.60 M | 2.39 M | 13.70 M | 23.10 M | 24.55 M | 28.24 M | 32.95 M | 36.73 M | 54.00 M | 73.06 M | ||||||||||
| Low Estimate | 6.05 M | 8.98 M | 1.23 M | 6.35 M | 1.33 M | 2.87 M | 2.40 M | 2.03 M | 12.44 M | 20.29 M | 22.12 M | 25.83 M | 30.73 M | 30.72 M | 48.29 M | 61.86 M | ||||||||||
| Consensus Estimate | 6.63 M | 9.84 M | 1.32 M | 6.89 M | 1.45 M | 3.00 M | 2.50 M | 2.21 M | 13.07 M | 21.70 M | 23.33 M | 27.04 M | 31.84 M | 33.73 M | 51.14 M | 67.46 M |
Analysts expect Denali Therapeutics Inc. to report earnings per share of -0.35 for Q3 26, against a range of -0.36 to -0.34. The most recent reported quarter, Q2 26, came in at -0.68, a 41.7% miss against the -0.48 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.63 | -0.67 | -0.78 | -0.72 | -0.74 | -0.73 | -0.69 | -0.68 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.57 | -0.72 | -0.61 | -0.72 | -0.72 | -0.65 | -0.63 | -0.46 | -0.34 | -0.55 | -0.61 | -0.63 | -0.56 | -0.47 | -0.47 | -0.46 | ||||||||||
| Low Estimate | -0.69 | -0.80 | -0.73 | -0.80 | -0.86 | -0.77 | -0.75 | -0.50 | -0.36 | -0.63 | -0.69 | -0.69 | -0.64 | -0.55 | -0.51 | -0.56 | ||||||||||
| Consensus Estimate | -0.63 | -0.76 | -0.67 | -0.76 | -0.79 | -0.71 | -0.69 | -0.48 | -0.35 | -0.59 | -0.65 | -0.66 | -0.60 | -0.51 | -0.49 | -0.51 |
Pull Wall Street consensus for Denali Therapeutics Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=DNLI&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "DNLI", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=DNLI&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();